Today's Healthcare Pulse
FDA greenlights durvalumab combo for high‑risk bladder cancer
The FDA approved durvalumab (Imfinzi) combined with Bacillus Calmette‑Guerin for BCG‑naïve, high‑risk non‑muscle invasive bladder cancer. The POTOMAC trial enrolled 1,018 patients and showed a 32% reduction in disease recurrence risk (hazard ratio 0.68, p=0.015). Durvalumab is given at 1,500 mg IV every four weeks for up to 13 cycles.
Also developing:
By the numbers: Apogee Therapeutics raises $1.3B royalty financing
Hims & Hers Earnings Preview: The Novo Nordisk Shift Puts GLP-1 Strategy in Focus
Hims & Hers Health has closed a settlement with Novo Nordisk and begun selling the Danish firm’s brand‑name GLP‑1 drugs Wegovy and Ozempic through its telehealth platform. The partnership was announced in March, but the products only entered the marketplace at the end of the month, so revenue impact is likely to appear in Q2 rather than the upcoming Q1 report. The company’s subscriber base now exceeds 2.5 million, with strong three‑month retention, while analysts expect earnings per share of just 3‑4 cents, a steep YoY drop. With short interest above 35% and a volatile price swing, the May 11 earnings release will test whether the strategic shift can sustain the recent rally.
A Light at the End of the Tunnel for Huntington’s Disease Treatment
Researchers at Florida Atlantic University have uncovered a cellular pathway that enables mutant huntingtin protein (mHTT) to travel between neurons via tunneling nanotubes (TNTs). Using LC‑MS/MS, they identified the intracellular pH sensor Slc4a7 as a critical membrane partner of the...
Factors Contributing to the Growth of Radiopharmaceuticals: Q&A with Andrea Zobel and Marco Hogenboom
Radiopharmaceuticals are poised for rapid expansion, with the market expected to grow from $9.07 billion in 2023 to $26.51 billion by 2031, driven by innovative radioligand therapies and a surge in clinical trials. World Courier’s senior directors Andrea Zobel and Marco Hogenboom...
MAHA Split Over New Surgeon General
In this episode of CareTalk, hosts David Williams and John Driscoll dissect the fallout from Casey Means' failed Surgeon General nomination and examine the administration’s pivot to Dr. Nicole "Sapphire" Sloan, a Fox News‑regular radiologist with an active medical license. They...
Webinar Q&A Follow Up: Immunoassay Signal Amplification: Bold New Solutions for Existing ELISAs
Cavidi’s principal scientist Peter Stenlund explained how the BOLD signal‑amplification platform boosts ELISA sensitivity by lowering the lower limit of quantification while modestly reducing the upper limit. The technology relies on click‑chemistry conjugation of stable DBCO‑modified oligos, offering precise stoichiometry...
How to Fix Your Claim Denial Rate with Expert Outsourcing
Medical practices lose revenue when claim denials rise, often because internal staff are stretched between patient care and complex billing tasks. Expert outsourcing of revenue cycle management introduces rigorous pre‑submission auditing, certified coders, and proactive workflows that address coding errors,...
Microsure Receives CE Mark for MUSA-3 System and Appoints New CEO
Dutch medical‑technology firm Microsure announced that its MUSA‑3 robotic system has received CE mark approval, allowing the device to be used clinically across Europe. The clearance moves the company from development to a commercial medical‑device business focused on generating clinical...
MEDSIR Reports PHERGain and PHERGain-2 Trial Results for Breast Cancer
MEDSIR presented Phase II data from the PHERGain and PHERGain‑2 trials, exploring chemotherapy‑free strategies for early HER2‑positive breast cancer. PHERGain showed that PET‑guided use of trastuzumab and pertuzumab allowed roughly 30% of patients to omit chemotherapy while achieving nearly 90% five‑year...
Tariffs and Geopolitical Disruption Reshape Global Pharma Supply Chains
The U.S. administration has introduced tariffs on imported pharmaceuticals and their ingredients, reshaping trade rules and encouraging on‑shoring of drug manufacturing. The policy couples incentives with pricing agreements, prompting companies to invest tens of billions in expanding domestic production. Simultaneously,...
Qualitative Findings on the Benefits of Depression Treatment for Pregnant Women Living with HIV in Uganda
A qualitative sub‑study of the M‑DEPTH cluster trial in Uganda interviewed 25 pregnant women living with HIV who received either antidepressant therapy or problem‑solving therapy. Nearly all participants (23 of 25) reported relief from depressive symptoms, better adherence to antiretroviral...
Listen: A Federal Agency Is After Workers’ Health Data, and Critics Are Alarmed
The Office of Personnel Management (OPM) has asked health insurers for unredacted medical records of federal employees, a move that would give the government detailed personal health information. The request, highlighted by KFF Health News, has sparked alarm among privacy...
Diabetes 'Wonder Drug' Doesn't Work Like Expected – but It's Good News
Northwestern researchers have demonstrated that metformin’s glucose‑lowering effect originates in the gut, not the liver, by inhibiting mitochondrial complex I in intestinal cells. This inhibition turns the intestine into a glucose sink, increasing uptake and converting excess sugar to lactate and...
Venom and Hot Peppers Offer a Key to Killing Resistant Bacteria
Researchers at Mexico’s UNAM have created three new antibiotics from scorpion venom and habanero pepper compounds. Two benzoquinone molecules from Diplocentrus melici venom show activity against tuberculosis, Staphylococcus aureus and Acinetobacter baumannii, while a defensin peptide from Capsicum chinense targets...
Insurance Coverage and Provision of Opioid Disorder Treatment
Older‑adult opioid overdose deaths have surged, prompting policy action. In 2020 Medicare began covering methadone, the first FDA‑approved medication for opioid use disorder available only through opioid treatment programs. Using a difference‑in‑differences design, researchers found that OTPs quickly expanded Medicare...
Why You Should Visit a Dentist at the First Tooth Pain in Livingston
The article urges residents of Livingston, New Jersey to schedule a dental appointment at the first sign of tooth pain. It explains that mild sensitivity often masks decay, gum disease, or infection that can quickly worsen. Early visits usually involve...
How Clinical Teams Can Use Virtual Support to Reclaim Patient Time
Physicians now spend roughly two hours on paperwork for every hour of patient care, fueling burnout and limiting clinic capacity. Virtual medical assistants are being deployed to manage pre‑visit chart preparation, after‑visit summaries, and routine coordination tasks. By offloading documentation,...
How Health Insurance Supports Long-Term Financial Stability For Dallas–Fort Worth Households
Health insurance is a critical component of long‑term financial stability for households in the Dallas‑Fort Worth metroplex. By absorbing unexpected medical costs, it protects savings, supports consistent budgeting, and enables families to pursue goals such as home ownership or education....
ALX Oncology Presents P-I/II Trial Data on Evorpacept Combination in Metastatic Breast Cancer (mBC) at ESMO Breast Cancer’26
ALX Oncology reported exploratory Phase Ib/II data on evorpacept combined with Ziihera in 24 heavily pre‑treated HER2‑positive metastatic breast cancer patients, all of whom had previously received Enhertu. Overall, the regimen achieved a 33% confirmed overall response rate (cORR) with...
MS Cases Rise in England as Survival Improves but Inequalities Remain
Multiple sclerosis (MS) prevalence in England more than doubled between 2000 and 2020, rising from just under 22,000 to over 37,000 diagnosed patients, with estimates suggesting roughly 190,000 people now live with the disease. Survival has improved markedly; cohorts diagnosed...
No Deal Reached at CUPE Long Term Care Table
Long‑term care workers represented by the Canadian Union of Public Employees (CUPE) failed to secure a new contract with the Nova Scotia government, leaving negotiations deadlocked. The government’s latest proposal would lift wages to just over $23 CAD (about $17...
Cera and uMed Announce New Partnership
Cera, Europe’s largest HealthTech provider, has partnered with uMed’s automated living registry platform to bring clinical trial recruitment into patients’ homes. The collaboration leverages Cera’s network of over 2.5 million monthly home‑care visits and uMed’s regulated digital consent platform to reach...
Opposition Forming Against Radiologist Nominee for Surgeon General
President Donald Trump announced radiologist Nicole B. Saphier, a breast‑cancer specialist at Memorial Sloan Kettering, as his new surgeon‑general pick, replacing wellness influencer Casey Means. The nomination has sparked opposition from the Make American Healthy Again (MAHA) coalition, which argues...
Google Launches AI Health Coach to Interpret Wearable Data
Wearables can measure every vital sign or health parameter that matters in adjusting your lifestyle. But what the user does with the data remains the biggest challenge. Now Google wants to solve that too. After OpenAI and Anthropic came up with...
PSMA PET Imaging’s Proliferation Produces Uptick in Aggressive Treatment for Prostate Cancer
Prostate-specific membrane antigen (PSMA) PET imaging, FDA‑approved in 2021, has rapidly displaced conventional bone scans among U.S. insurers, becoming the dominant diagnostic tool for advanced prostate cancer by 2023. A national Blue Cross Blue Shield claims analysis of nearly 6,000...
Beacon Therapeutics Reports P-II (DAWN) Trial Data on Laru-Zova in X-Linked Retinitis Pigmentosa (XLRP)
Beacon Therapeutics presented 12‑month data from its Phase‑2 DAWN trial of laruparetigene zovaparvovec (laru‑zova) in patients with X‑linked retinitis pigmentosa (XLRP) who previously received an AAV‑RPGR gene therapy. The study showed sustained gains in low‑luminance visual acuity (LLVA) and microperimetry mean...
Dis-Chem Unveils Health Hub In Melrose Arch
Dis‑Chem has opened its first Melrose Arch Health Hub, a one‑stop location that merges a clinic, pharmacy and health‑cover services under one roof. The Hub uses a digital ticketing system, nurse‑led consultations, virtual GP access and a data‑driven store layout...
Solar Backup Power Supports Ukrainian Intensive Care Units During Grid Outages and Cyberattacks
At the SolarPower Summit in Brussels, Ukrainian representatives highlighted how solar‑plus‑storage systems are keeping hospitals and schools operational amid grid outages and cyberattacks. Energy Act for Ukraine, led by Yuliana Onishchuk, has installed nearly 1.5 MW of photovoltaic capacity and 2 MWh...
Dual‑LAO Accelerates Robust Binding Free Energy Calculations
New paper published @CommsChem with the @qubit_pharma team led by @Narjes_Ansari: "Dual-LAO for calculating fast and robust relative binding free energies of simple and complex transformations" (#OpenAccess) #compchem #drugdesign @FefeAviat J. Hénin L. Lagardère https://t.co/ktdX8AWMBo
Semaglutide Race: Torrent Grabs 38% Market Share
Torrent Pharma has seized a 38% share of India’s generic semaglutide market within a month of launch, generating about ₹17 crore ($2 million) in April sales. Generic semaglutide revenue reached ₹44 crore ($5.3 million), while total market sales—including Novo Nordisk’s innovator—hit roughly ₹89 crore ($10.7 million)....
Latest Middle East Partnerships Expanding Korean Health Tech and More Briefs
South Korean medtech firms ROKIT Healthcare and Seers are forging Middle East partnerships to deploy AI‑enabled kidney disease prediction and ECG monitoring solutions, with Seers securing a $15 million three‑year distribution deal for 105,000 mobiCARE devices in the UAE. In parallel,...
IVERMECTIN and FENBENDAZOLE Testimonial - 70 Year Old UK Woman with NHL B-Cell Lymphoma Reports After 5 Months - in...
A 70‑year‑old woman in the United Kingdom diagnosed with B‑cell non‑Hodgkin lymphoma posted a personal testimonial claiming near remission after five months of self‑administered ivermectin and fenbendazole. The post attributes her improvement to the off‑label use of these antiparasitic drugs,...
This Week in European MedTech and HealthTech: 8th May 2026
The European Commission activated the first four EUDAMED modules, prompting a data‑cleansing rush among MedTech firms. Updated EU AI Act guidance now obliges manufacturers of high‑risk medical AI to provide understandable explanations to patients. French health‑tech unicorn Doctolib announced a...
IHH Healthcare Migrating Finance, HR Systems to the Cloud and More Briefs
Private healthcare giant IHH Healthcare announced it will migrate its legacy finance, human resources and supply chain applications to Oracle Fusion Cloud, creating a unified, cloud‑based platform. The move follows earlier cloud migrations of on‑premise databases in its Singapore and...
Bristol NHS Group Opens Doors to Tech Providers to Inspire Staff, in Flagship Elevate Showcase
Bristol NHS Group is hosting its Elevate Local Health Tech Showcase on 13 May at BAWA Health & Leisure, bringing together NHS staff, university partners and a mix of major and niche technology providers. The event is part of the...
Schneider Shorts 8.05.2026 – Incredible Future Is Now Becoming Reality
The biotech sector faced a series of high‑profile setbacks in early May 2026. Amgen was forced to withdraw its drug avacopan after the FDA uncovered fabricated trial data, a scandal tied to a $4 billion acquisition of ChemoCentryx. Russia announced a...
Hong Kong Urged to Step up Rodent Checks Despite No Local Residents on Hantavirus-Hit Cruise Ship
Infectious disease specialist Dr. Joseph Tsang urged Hong Kong's Agriculture, Fisheries and Conservation Department to intensify rodent monitoring after a hantavirus outbreak on the Atlantic‑bound cruise MV Hondius. The Centre for Health Protection confirmed that no Hong Kong residents were...
University Explores Endometriosis and Cancer Link
Researchers at the University of Northampton are investigating whether endometriosis contributes to the development and spread of ovarian cancer. Led by immunology lecturer Danielle Jex, the team is examining chemical signals released by endometriosis cells that might help cancer cells...
Week in Review
This week’s regulatory roundup featured a U.S. Supreme Court order pausing a Fifth Circuit ban on telehealth‑only access to the abortion drug mifepristone, a $1.5 million civil‑penalty settlement between the SEC and Elon Musk over undisclosed Twitter (X) stock holdings, and...
FDA’s Expedited Drug Reviews Are Hailed in some Quarters but Other Approval Practices Are Problematic
In July 2025 the FDA launched the Commissioner’s National Priority Voucher (CNPV) pilot to slash drug review times from six‑to‑eight months down to one‑or‑two months, issuing 17 vouchers for therapies ranging from cancer to cholesterol drugs. Commissioner Marty Makary later...
Vaccine Shootout at the CDC
President Trump recently reshaped the CDC leadership by nominating Dr. Erica Schwartz as the agency’s director, signaling a pro‑vaccine stance. At the same time, he appointed Dr. Sara Brenner, an FDA deputy known for her “MAHA mom” advocacy, as senior counselor...
Chronic Pain in Mental Disorders: A Widely Overlooked Comorbidity
An umbrella review of 20 systematic reviews and large primary studies covering over 950,000 individuals with mental disorders found chronic pain to be highly prevalent across psychiatric conditions. Rates range from 23.7% in bipolar disorder to 53‑65% in depression and...
Autonomous Robot Achieves Zero‑Error Blood Draws
Zero-Error Blood Draws: Fully #Autonomous #Robot Handles Vein Detection to Injection by @Berci #MedTech #Healthcare #HealthTech #Tech #Technology https://t.co/2ZzoRdwtqP
Trump Administration Cuts CDC’s Key Role in Global Program to Stop HIV
The Trump administration’s May 5 guidance ends the CDC’s involvement in the President’s Emergency Plan for AIDS Relief (PEPFAR) for most of the 46 recipient countries. Congress has earmarked $4.5 billion for PEPFAR this fiscal year, but the State Department now wants...
Boomers 80, $79T Wealth Fuels Healthcare Boom
A decade ago. We were lectured and lectured and lectured again - over and over again from Wall St. analysts. "The USA has an aging population. Health care is the undeniable sector of the future." Today, the oldest baby boomer...
Trump’s New Drug Advertising Proposals Fall Short on Public Health and the Constitution
The Trump administration’s FY 2027 budget proposes two contrasting measures: a sensible requirement that compounding pharmacies prominently disclose that their products have never been evaluated by the FDA, and a broader effort to give the FDA new authority to deem FDA‑approved...
Re: Arthroscopic Subacromial Decompression versus Placebo Surgery for Subacromial Pain Syndrome: 10 Year Follow-Up of the FIMPACT Randomised, Placebo Surgery...
The author applauds the FIMPACT trial’s 10‑year follow‑up, which retained 87% of participants, but argues that extensive crossovers blur the original "ASD versus placebo" comparison. By year ten, the analysis effectively compares patients who received arthroscopic subacromial decompression (ASD) early...
Doctors Warn This Popular Vitamin May Quietly Disrupt Cancer Care
Biotin supplements have become a popular self‑treatment for hair loss among cancer patients, despite limited scientific proof of benefit. Oncologists warn that biotin can skew blood‑test results used to monitor prostate, thyroid, ovarian and breast cancers, potentially delaying or altering...
Odyssey Raises More than $300M as Biotech Goes Public
Odyssey Therapeutics completed a Nasdaq debut, raising $279 million by selling 15.5 million shares in its initial public offering. The biotech, focused on autoimmune‑disease therapeutics, priced the offering at $18 per share, above the $16.50 low end of its range. Proceeds will...
Research Links Muscle Loss, Weaker Grip and Slower Walking Pace to Higher Risk of Stroke
A new UK Biobank analysis published in *Stroke* links muscle loss, weaker grip strength, and slower walking pace to a markedly higher risk of stroke. Adults with low muscle strength faced a 30% rise in overall stroke risk, while a...
Generally Good Indian Pharma Companies
An audit of top‑tier Indian generic manufacturers evaluated 20 therapeutic compounds based on market cap, API integration, ANDA volume, and GMP compliance. The review highlights Cipla, Sun Pharma and Zydus as leaders for propranolol, cardiovascular agents, and complex molecules like...